Mathilde Varret Selected Research

Apolipoproteins E (ApoE)

12/2023	Corrigendum to "APOE gene variants in primary dyslipidemia" [Atherosclerosis (2021 Jul) 328 11-22].
1/2023	Additive Effect of APOE Rare Variants on the Phenotype of Familial Hypercholesterolemia.
5/2022	APOE Molecular Spectrum in a French Cohort with Primary Dyslipidemia.
3/2022	Whole Exome/Genome Sequencing Joint Analysis of a Family with Oligogenic Familial Hypercholesterolemia.
1/2021	APOE gene variants in primary dyslipidemia.
1/2018	Usefulness of the genetic risk score to identify phenocopies in families with familial hypercholesterolemia?
1/2013	Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mathilde Varret Research Topics

Disease

26	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 09/2023 - 08/2002
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 11/2005
6	Hypercholesterolemia 05/2022 - 11/2005
6	Coronary Disease (Coronary Heart Disease) 12/2021 - 06/2003
5	Dyslipidemias (Dyslipidemia) 12/2023 - 12/2016
3	Atherosclerosis 12/2023 - 02/2015
3	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 05/2022 - 01/2013
3	Inborn Genetic Diseases (Disease, Hereditary) 03/2022 - 01/2003
2	Stroke (Strokes) 12/2021 - 10/2018
2	Thoracic Aortic Aneurysm 01/2021 - 12/2014
2	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2021 - 01/2013
2	Coronary Artery Disease (Coronary Atherosclerosis) 02/2015 - 03/2013
1	Homozygous Familial Hypercholesterolemia 01/2023
1	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Inflammation (Inflammations) 12/2021
1	Infarction (Infarctions) 12/2021
1	Aortic Valve Stenosis (Aortic Stenosis) 12/2021
1	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 08/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Lipoprotein Glomerulopathy 01/2021
1	Abetalipoproteinemia (Bassen Kornzweig Syndrome) 01/2019
1	Myocardial Infarction 10/2018
1	Unstable Angina 10/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Sea-Blue Histiocyte Syndrome (Sea Blue Histiocytosis) 01/2013
1	Primary Hypertrophic Osteoarthropathy (Hypertrophic Osteoarthropathy, Primary) 08/2012
1	Primary Myelofibrosis (Myelosclerosis) 08/2012
1	Chylomicron retention disease 01/2011
1	Malabsorption Syndromes (Malabsorption Syndrome) 01/2011
1	Xanthomatosis (Xanthoma) 05/2010
1	Diffuse Scleroderma (Progressive Systemic Sclerosis) 04/2010
1	Systemic Scleroderma (Systemic Sclerosis) 02/2009
1	Genetic Predisposition to Disease (Genetic Predisposition) 02/2009
1	Marfan Syndrome (Marfan's Syndrome) 08/2004
1	Neoplasms (Cancer) 08/2004
1	3 Autosomal Dominant Hypercholesterolemia 06/2003

Drug/Important Bio-Agent (IBA)

13	Apolipoproteins B (ApoB)IBA 01/2023 - 01/2003
13	LDL CholesterolIBA 01/2023 - 06/2003
11	LDL Receptors (LDL Receptor)IBA 09/2023 - 08/2002
11	ApolipoproteinsIBA 08/2021 - 01/2003
10	Proprotein Convertase 9IBA 09/2023 - 06/2003
8	CholesterolIBA 12/2021 - 11/2005
7	Apolipoproteins E (ApoE)IBA 12/2023 - 01/2013
7	oxidized low density lipoproteinIBA 09/2023 - 11/2005
6	LDL Lipoproteins (beta Lipoproteins)IBA 03/2013 - 04/2009
5	LipidsIBA 01/2023 - 01/2011
5	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 12/2016 - 07/2009
4	Triglycerides (Triacylglycerol)IBA 05/2022 - 01/2013
4	SubtilisinIBA 12/2016 - 11/2010
3	Lipoproteins (Lipoprotein)IBA 01/2022 - 01/2019
2	1,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA 01/2021 - 12/2014
2	ProstaglandinsIBA 01/2021 - 08/2012
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2011
2	Apolipoprotein B-100 (Apo B 100)IBA 12/2012 - 05/2012
2	LigandsIBA 07/2009 - 04/2009
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2023
1	ChylomicronsIBA 01/2022
1	Streptozocin (Streptozotocin)FDA Link 12/2021
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 12/2021
1	Lipoprotein(a)IBA 12/2021
1	Ephrin-B2 (Ephrin B2)IBA 12/2021
1	Apolipoprotein E2IBA 01/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021
1	Prostaglandin D2IBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	O(4)-methylthymidine triphosphateIBA 01/2019
1	microsomal triglyceride transfer proteinIBA 01/2019
1	AntibodiesIBA 10/2017
1	PCSK9 InhibitorsIBA 12/2016
1	Fibrillin-1IBA 04/2010
1	subtilinIBA 07/2009
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 02/2009
1	F 382IBA 11/2005
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 08/2004
1	Transforming Growth Factor-beta Type II ReceptorIBA 08/2004
1	FibrillinsIBA 08/2004

Therapy/Procedure

2	Therapeutics 10/2017 - 12/2016
1	Bariatric Surgery 01/2022
1	Electrocoagulation (Electrocautery) 12/2021
1	Percutaneous Coronary Intervention 10/2018